Background
COVID-19 has ushered in a new wave of healthcare innovations from technological adoption to regulatory updates across the pharma and medical device industry in Asia.
In this summit, we bring you the latest insights and expert perspectives on how pharma and medical device can keep up with digital health;how they can create patient-centered digital health innovations; and how they can activate new business segments via digital health to drive business digital growth.
Hot Points
1.Patient-centric Digital Healthcare
What are the roles of enterprises, platforms, doctors and institutions in patient-centric healthcare model? How to better serve patients? How to build a comprehensive medical ecosystem integrating medical service, pharmaceutics, medical insurance and patient? How to innovate patient management mode?
2.Digital Therapeutics
What is digital therapeutics? How can digital therapeutics bring value to different parties in the industry? How to implement digital therapeutics?
3.HCP Engagement Innovation
Transformative technologies like HCP engagement management deliver a solution that integrates with existing IT ecosystems. How to have better business processes while adhering to compliance regulations?
4.Pricing and Market Access
Increasingly, payers, providers and regulators are looking at new types of data and evidence when evaluating price and value – especially for innovative products. Understanding how these stakeholders define value, which evidence data matters, and where your portfolio may face risk around the world is an essential element in Asia market access strategy to protect and expand commercial success.
5.Digital Marketing
What’s the impact of COVID-19 on the Asia digital marketing in pharma market? What value can digital marketing bring to enterprises?
6.Healthcare Regulations
As regulations governing pharma and medical devices and technology continue to evolve around the world. How can we protect patient privacy and use regulatory intelligence to meet the compliance goals?